Back

Safety and efficacy of very high-power short ablation in superior vena cava isolation in patients with atrial fibrillation

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: treatment 3 - ablation Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Yuhi Fujimoto

Nippon Medical School Teaching Hospital, Tokyo (Japan)

7 More presentations in this session

Presentation thumbnail
Very-high power short duration radiofrequency ablation (90W/4seconds) under mild conscious sedation: lesion metrics and 12-month outcomes
Doctor M. Mills (Sheffield, GB)
Abstract Slides Video
Presentation thumbnail
The impact of cardiac rehabilitation on atrial fibrillation recurrence after pulmonary vein isolation: results of a retrospective study.
Miss R. Onder (Hasselt, BE)
Abstract Slides Video
Presentation thumbnail
Pressure-guided evaluation of pulmonary vein occlusion during cryoballoon pulmonary vein isolation for atrial fibrillation compared to contrast-guided approach
Mr O. Alothman (Bad Berka, DE)
Abstract Slides Video
Presentation thumbnail
Low voltage area in the left atrial anterior wall predict Marshall-PLAN failure in patients with persistent atrial fibrillation.
Doctor L. Limite (Perpignan, FR)
Abstract Slides Video
Presentation thumbnail
Endoscopic versus surgical treatment for the management of oesophageal fistula after atrial fibrillation ablation - a subanalysis of the worldwide POTTER-AF study
Doctor S. Popescu (Luebeck, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: treatment 3 - ablation

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
High power short duration and very high power short duration protocol: a comparison between two effective strategies of atrial fibrillation transcatheter ablation with radiofrequency
thumbnail
Congress Presentation
Enhancing efficiency in pulmonary vein isolation: hybrid high-power strategy with consistent long-term recurrence rates
thumbnail
Congress Presentation
Pulmonary vein isolation durability in patients undergoing very high-power short-duration temperature-controlled ablation.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources